Advertisement
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Brodey RS, Craig PH. Primary pulmonary neoplasms in the dog: a review of 29 cases. J Am Vet Med Assoc. 1965;147(12):1628–1643.
-
2.
Moulton JE, von Tscharner C, Schneider R. Classification of lung carcinomas in the dog and cat. Vet Pathol. 1981;18(4):513–528.
-
3.
Nielsen SW, Horava A. Primary pulmonary tumors of the dog. A report of 16 cases. Am J Vet Res. 1960;21:813–830.
-
4.
López A, Martinson SA. Respiratory system, mediastinum, and pleurae. In: James Z, ed. Pathologic Basis of Veterinary Disease Expert Consult. 6th ed. Elsevier; 2016:471–560.
-
5.
Caswell JL, Williams KJ. Respiratory system. In: Maxie G, ed. Jubb, Kennedy, and Palmer’s Pathology of Domestic Animals. 6th ed. Elsevier; 2016:95–500.
-
6.
Ogilvie GK, Haschek WM, Withrow SJ, et al. Classification of primary lung tumors in dogs 210 cases. J Am Vet Med Assoc. 1989;195(1):106–108.
-
7.
Vignoli M, Buchholz J, Morandi F, et al. Primary pulmonary spindle cell tumour (haemangiopericytoma) in a dog. J Small Anim Pract. 2008;49(10):540–543.
-
8.
Marlowe KW, Robat CS, Clarke DM, et al. Primary pulmonary histiocytic sarcoma in dogs: a retrospective analysis of 37 cases (2000–2015). Vet Comp Oncol. 2018;16(4):658–663.
-
9.
Dhumeaux MP, Haudiquet PR. Primary pulmonary osteosarcoma treated by thoracoscopy-assisted lung resection in a dog. Can Vet J. 2009;50(7):755–758.
-
10.
Cartagena-Albertus JC, Moise A, Moya-García S, Cámara-Fernández N, Montoya-Alonso JA. Presumptive primary intrathoracic mast cell tumours in two dogs. BMC Vet Res. 2019;15(1):204. doi: 10.1186/s12917-019-1950-5
-
11.
Rebhun R, Culp W. Tumors of the respiratory system, section D: pulmonary neoplasia. In: Withrow SJ, Vail DM, Page RL, eds. Withrow and MacEwen’s Small Animal Clinical Oncology. 5th ed. Elsevier; 2013:432–462.
-
12.
Lung lobe tumors. American College of Veterinary Surgeons. Accessed September 4, 2020. https://www.acvs.org/small-animal/lung-lobe-tumors
-
13.
McNeil EA, Ogilvie GK, Powers BE, Hutchison JM, Salman MD, Withrow SJ. Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985–1992). J Am Vet Med Assoc. 1997;211(11):1422–1427.
-
14.
Ogilvie GK, Weigel RM, Haschek WM, et al. Prognostic factors for tumor remission and survival in dogs after surgery for primary lung tumor: 76 cases (1975–1985). J Am Vet Med Assoc. 1989;195(1):109–112.
-
15.
Lee BM, Clarke D, Watson M, Laver T. Retrospective evaluation of a modified human lung cancer stage classification in dogs with surgically excised primary pulmonary carcinomas. Vet Comp Oncol. 2020;18(4):590–598.
-
16.
Polton GA, Brearley MJ, Powell SM, Burton CA. Impact of primary tumour stage on survival in dogs with solitary lung tumours. J Small Anim Pract. 2008;49(2):66–71.
-
17.
Rose RJ, Worley DR. A contemporary retrospective study of survival in dogs with primary lung tumors: 40 cases (2005–2017). Front Vet Sci. 2020;7:519703. doi: 10.2289/fvets.2020.519703
-
18.
O’Sullivan B, Brierley J, Byrd D, et al. The TNM classification of malignant tumours—towards common understanding and reasonable expectations. Lancet Oncol. 2017;18(7):849–851.
-
19.
Ogilvie GK, Obradovich JE, Elmslie RE, et al. Efficacy of mitoxantrone against various neoplasms in dogs. J Am Vet Med Assoc. 1991;198(9):1618–1621.
-
20.
Ogilvie GK, Reynolds HA, Richardson R, et al. Phase II evaluation of doxorubicin for treatment of various canine neoplasms. J Am Vet Med Assoc. 1989;195(11):1580–1583.
-
21.
Poirier VJ, Burgess KE, Adams WM, Vail DM. Toxicity, dosage, and efficacy of vinorelbine (Navelbine) in dogs with spontaneous neoplasia. J Vet Intern Med. 2004;18(4):536–539.
-
22.
Veterinary Cooperative Oncology Group—common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1. Vet Comp Oncol. 2016;14(4):417–446.
-
23.
Follette CM, Giuffrida MA, Balsa IM, et al. A systematic review of criteria used to report complications in soft tissue and oncologic surgical clinical research studies in dogs and cats. Vet Surg. 2020;49(1):61–69.
-
24.
Lenz JA, Furrow E, Craig LE, Cannon CM. Histiocytic sarcoma in 14 Miniature Schnauzers—a new breed predisposition? J Small Anim Pract. 2017;58(8):461–467.
-
25.
Kagawa Y, Nakano Y, Kobayashi T, Asano K, Takagi S. Localized pulmonary histiocytic sarcomas in Pembroke Welsh Corgi. J Vet Med Sci. 2016;77(12):1659–1661.
-
26.
Choi US, Alleman AR, Choi J-H, Kim HW, Youn H-J, Lee CW. Cytologic and immunohistochemical characterization of a lung carcinoid in a dog. Vet Clin Pathol. 2008;37(2):249–252.
-
27.
Harkema JR, Jones SE, Naydan DK, Wilson DW. An atypical neuroendocrine tumor in the lung of a Beagle dog. Vet Pathol. 1992;29(2):175–179.
-
28.
Gould EN, Johnson LR, Traslavina RP, Mohr FC. Neuroendocrine tumour at the carina of a dog. J Comp Pathol. 2013;149(2-3):233–236.
-
29.
Saegusa S, Yamamura H, Morita T, Hasegawa A. Pulmonary neuroendocrine carcinoma in a four-month-old dog. J Comp Pathol. 1994;111(4):439–443.
-
30.
Abdel-Rahman O. Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system. Clin Transl Oncol. 2018;20(5):670–677.
-
31.
Dungworth DL. Histological classification of tumors of the respiratory system of domestic animals. In: Baba AI, Câtoi C, eds. Comparative Oncology. 2nd ed. The Publishing House of the Romanian Academy; 2007:1–99.
-
32.
Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med. 2013;137(5):668–684.
-
33.
Paoloni MC, Adams WM, Dubielzig RR, Kurzman I, Vail DM, Hardie RJ. Comparison of results of computed tomography and radiography with histopathologic findings in tracheobronchial lymph nodes in dogs with primary lung tumors: 14 cases (1999–2002). J Am Vet Med Assoc. 2006;228(11):1718–1722.
Advertisement
Distribution of histopathologic types of primary pulmonary neoplasia in dogs and outcome of affected dogs: 340 cases (2010–2019)
Abstract
OBJECTIVE
To provide updated information on the distribution of histopathologic types of primary pulmonary neoplasia in dogs and evaluate the effect of postoperative adjuvant chemotherapy in dogs with pulmonary carcinoma.
ANIMALS
340 dogs.
PROCEDURES
Medical records of dogs that underwent lung lobectomy for removal of a primary pulmonary mass were reviewed, and histopathologic type of lesions was determined. The canine lung carcinoma stage classification system was used to determine clinical stage for dogs with pulmonary carcinoma.
RESULTS
Pulmonary carcinoma was the most frequently encountered tumor type (296/340 [87.1%]), followed by sarcoma (26 [7.6%]), adenoma (11 [3.2%]), and pulmonary neuroendocrine tumor (5 [1.5%]); there was also 1 plasmacytoma and 1 carcinosarcoma. Twenty (5.9%) sarcomas were classified as primary pulmonary histiocytic sarcoma. There was a significant difference in median survival time between dogs with pulmonary carcinomas (399 days), dogs with histiocytic sarcomas (300 days), and dogs with neuroendocrine tumors (498 days). When dogs with pulmonary carcinomas were grouped on the basis of clinical stage, there were no significant differences in median survival time between dogs that did and did not receive adjuvant chemotherapy.
CLINICAL RELEVANCE
Results indicated that pulmonary carcinoma is the most common cause of primary pulmonary neoplasia in dogs; however, nonepithelial tumors can occur. Survival times were significantly different between dogs with pulmonary carcinoma, histiocytic sarcoma, and neuroendocrine tumor, emphasizing the importance of recognizing the relative incidence of these various histologic diagnoses. The therapeutic effect of adjuvant chemotherapy in dogs with pulmonary carcinoma remains unclear and warrants further investigation.
Contributor Notes
Powered by PubFactory